Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)

In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro

Cancer Res Treat. 2019;51(1):43-52. Published online February 14, 2018 DOI: https://doi.org/10.4143/crt.2017.562

Web of Science 30 Crossref 34

ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer

Ji-Youn Han, Geon Kook Lee, Kun Young Lim, Young Ju Lee, Byung Ho Nam, Jin Soo Lee

Cancer Res Treat. 2017;49(3):678-687. Published online October 11, 2016 DOI: https://doi.org/10.4143/crt.2016.365

Web of Science 5 Crossref 2

A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors

Ji-Youn Han, Ki Hyeong Lee, Sang-We Kim, Young Joo Min, Eunkyung Cho, Youngjoo Lee, Soo-Hyun Lee, Hyae Young Kim, Geon Kook Lee, Byung Ho Nam, Hyesun Han, Jina Jung, Jin Soo Lee

Cancer Res Treat. 2017;49(1):10-19. Published online May 3, 2016 DOI: https://doi.org/10.4143/crt.2016.058

Web of Science 35 Crossref 33

A Study of Relationship of Atheroembolic Risk Factors with Postoperative Recovery in Renal Function after Partial Nephrectomy in Patients Staged T1-2 Renal Cell Carcinoma during Median 4-Year Follow-up

Sung Han Kim, Kyung Min Kang, Ami Yu, Jung Hoon Lee, Byung Ho Nam, Eun Sik Lee

Cancer Res Treat. 2016;48(1):288-296. Published online April 15, 2015 DOI: https://doi.org/10.4143/crt.2014.297

Web of Science 5 Crossref 3

Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410 FAX: +82-2-792-1410 E-mail: journal@cancer.or.kr

About | Browse Articles | Current Issue | For Authors and Reviewers